Comparative anti-anaerobic activity of Men 10700, a penem antibiotic (original) (raw)
Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003
Thomas Gottlieb
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Determination of antimicrobial susceptibilities of clinically isolated anaerobic bacteria by E-test, ATB-ANA and agar dilution
Mustafa Ozyurt
Anaerobe, 2008
View PDFchevron_right
Antimicrobial Susceptibility Profile of Clinical Isolates of Peptostreptococcus anaerobius
Kiran Chawla
Journal of Pure and Applied Microbiology, 2018
View PDFchevron_right
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 1986
View PDFchevron_right
Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2005
View PDFchevron_right
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics
L. Dubreuil
Antimicrobial Agents and Chemotherapy, 1984
View PDFchevron_right
Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
M. Ieven, Marijke Reynders
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria
manuel borobio
Antimicrobial Agents and Chemotherapy, 1980
View PDFchevron_right
Antimicrobial Resistance in Anaerobes
Karen Bush
Clinical Infectious Diseases, 1997
View PDFchevron_right
Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria
L. Dubreuil
International Journal of Antimicrobial Agents, 2006
View PDFchevron_right
Identification and detection of antibiotic susceptibility of the most common anaerobes causing infection in Surgical hospital, faculty of Medicine Zagazig University, Egypt.
IJAR Indexing
View PDFchevron_right
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece
Joseph Papaparaskevas
Clinical Microbiology and Infection, 2005
View PDFchevron_right
Comparative In Vitro Activity of PH-027 Versus Linezolid and Other Anti-Anaerobic Antimicrobials Against Clinical Isolates of Clostridium difficile and Other Anaerobic Bacteria
Oludotun Phillips
Journal of Chemotherapy, 2003
View PDFchevron_right
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
Anaerobic infections in cancer patients — A retrospective analysis of clindamycin, tindazole, doxycycline, cefoxitin and lamoxactam
Hjalmar Lagast
Infection, 1982
View PDFchevron_right
In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections
Ellie Goldstein
Anaerobe, 2006
View PDFchevron_right
Comparative Susceptibilities of Anaerobic Bacteria to Metronidazole, Ornidazole, and SC-28538
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 1978
View PDFchevron_right
Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents
Ellie Goldstein
Journal of Antimicrobial Chemotherapy, 2004
View PDFchevron_right
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria
Anthony Chow
Antimicrobial Agents and Chemotherapy, 1987
View PDFchevron_right
In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Comparison of Susceptibilities of Anaerobic Bacteria to Cefmenoxime, Ceftriaxone, and Other Antimicrobial Compounds
Ellen Baron
Antimicrobial Agents and Chemotherapy, 1983
View PDFchevron_right
Antibiotic susceptibility patterns of anaerobic bacteria isolated in Pretoria, South Africa, during 2003-2004
Delene Brink
Southern African Journal of Infectious Diseases, 2008
View PDFchevron_right
Comparative In Vitro Activities of Ertapenem (MK-0826) against 1,001 Anaerobes Isolated from Human Intra-Abdominal Infections
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2000
View PDFchevron_right
In Vitro Antimicrobial Activity of Razupenem (SMP-601, PTZ601) against Anaerobic Bacteria
Châu Trần
Antimicrobial Agents and Chemotherapy, 2011
View PDFchevron_right
E-test antibiotics susceptibility of strict anaerobic bacteria
serge houssaye
Anaerobe, 2003
View PDFchevron_right
In vitro activity of gemifloxacin (SB 265805) against anaerobes
Ellie Goldstein
Antimicrobial agents and chemotherapy, 1999
View PDFchevron_right
Resistance Trends in Antimicrobial Susceptibility of Anaerobic Bacteria, Part I
Ellie Goldstein
Clinical Microbiology Newsletter, 2011
View PDFchevron_right
Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing
Itzhak Brook
Clinical Microbiology Reviews, 2013
View PDFchevron_right
Comparative In Vitro Activities of Four Macrolides at Two pH Values Against Gram-negative Anaerobic Rods other than theBacteroides fragilis Group
Raquel Rollet, Liliana Canigia, Silvia Predari
Anaerobe, 1999
View PDFchevron_right
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 1985
View PDFchevron_right
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic …
Ellie Goldstein
Clinical infectious diseases, 2002
View PDFchevron_right
In Vitro Activity of Biapenem plus RPX7009, a Carbapenem Combined with a Serine -Lactamase Inhibitor, against Anaerobic Bacteria
Ellie Goldstein
Antimicrobial Agents and Chemotherapy, 2013
View PDFchevron_right
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes
Ellie Goldstein
Antimicrobial agents and chemotherapy, 1999
View PDFchevron_right
Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
Joyce Sutcliffe
Antimicrobial Agents and Chemotherapy, 2018
View PDFchevron_right